Methylation of SRD5A2 promoter predicts a better outcome for castration-resistant prostate cancer patients undergoing androgen deprivation therapy

PURPOSE: To determine whether SRD5A2 promoter methylation is associated with cancer progression during androgen deprivation therapy (ADT) in CRPC. PATIENTS AND METHODS: In a Local CRPC cohort, 42 prostatic specimens were collected from patients who were diagnosed as CRPC and underwent transurethral...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:PLoS One
मुख्य लेखकों: Wang, Zongwei, Deng, Tuo, Long, Xingbo, Lin, Xueming, Wu, Shulin, Wang, Hongbo, Ge, Rongbin, Zhang, Zhenwei, Wu, Chin-Lee, Taplin, Mary-Ellen, Olumi, Aria F.
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: Public Library of Science 2020
विषय:
Research Article
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC7058338/
https://ncbi.nlm.nih.gov/pubmed/32134978
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0229754
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन